Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease

Int J Mol Sci. 2022 Jun 28;23(13):7154. doi: 10.3390/ijms23137154.

Abstract

The available evidence indicates a close connection between gut microbiota (GM) disturbance and increased risk of cardiometabolic (CM) disorders and cardiovascular (CV) disease. One major objective of this narrative review is to discuss the key contribution of dietary regimen in determining the GM biodiversity and the implications of GM dysbiosis for the overall health of the CV system. In particular, emerging molecular pathways are presented, linking microbiota-derived signals to the local activation of the immune system as the driver of a systemic proinflammatory state and permissive condition for the onset and progression of CM and CV disease. We further outline how the cross-talk between sex hormones and GM impacts disease susceptibility, thereby offering a mechanistic insight into sexual dimorphism observed in CVD. A better understanding of these relationships could help unravel novel disease targets and pave the way to the development of innovative, low-risk therapeutic strategies based on diet interventions, GM manipulation, and sex hormone analogues.

Keywords: cardiometabolic disease; diet; gut microbiota; molecular mechanisms; sex hormone.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / etiology
  • Dysbiosis
  • Gastrointestinal Microbiome* / physiology
  • Gonadal Steroid Hormones / metabolism
  • Humans
  • Microbiota*

Substances

  • Gonadal Steroid Hormones

Grants and funding

This research received no external funding.